M. Ghahremani et al., ACTIVATION OF FAS LIGAND RECEPTOR SYSTEM KILLS OVARIAN-CANCER CELL-LINES BY AN APOPTOTIC MECHANISM/, Gynecologic oncology (Print), 70(2), 1998, pp. 275-281
The majority of ovarian cancers originate from the surface epithelium
of the ovary and from inclusion cysts derived from the epithelium that
becomes sequestered in the stroma. To identify naturally occurring li
gands that could activate mechanisms by which these ovarian neoplasms
could be eliminated, we have examined the ability of anti-Fas mAb to i
nduce apoptosis in two cell lines, HEY and Caov-3, derived from ovaria
n carcinomas of surface epithelial origin. Treatment of each cell line
with anti-Fas mAb caused chromatin condensation, nuclear segmentation
, and apoptotic body formation, indicative of apoptosis. Furthermore w
e have shown that anti-Fas mAb activates the sphingomyelin-ceramide si
gnal transduction pathway. Sphingomyelin levels were measured by norma
l-phase high-performance liquid chromatography interfaced with electro
spray mass spectrometry. The six most abundant sphingomyelin species i
dentified in Caov-3 cells were 34:1 (d18:1/16:0), 36:1 (d18:1/18:0), 4
0:1 (d18:1/22:0), 41:1(d18:1/23:0), 42:1 (d18:1/24:0), and 42:2 (d18:1
/24:1). Treatment of Caov-3 cells for 30 min caused a 40% decrease in
the total sphingomyelin content. Specifically three of these species,
34:1, 40:1, and 42:2, were reduced to 44, 70, and 54% of control value
s, respectively. The decrease was attributed to the hydrolysis of sphi
ngomyelin. Treatment of these cell lines with ceramide, a product of s
phingomyelin hydrolysis, using a cell-permeable synthetic ceramide ana
logue C-2-ceramide, also caused the above cells to undergo apoptosis.
Thus, the Fas ligand/receptor system, acting through the sphingomyelin
-ceramide pathway, provides a mechanism by which ovarian surface epith
elial cancer cells can be induced to undergo apoptosis. (C) 1998 acade
mic Press.